blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2802598

EP2802598 - PEPTIDES AND PEPTIDE DERIVATIVES BASED ON XENIN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.10.2018
Database last updated on 02.09.2024
FormerThe patent has been granted
Status updated on  03.11.2017
FormerGrant of patent is intended
Status updated on  27.06.2017
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL, IS		published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
University Of Ulster
Cromore Road
Coleraine
County Londonderry BT52 1SA / GB
[2014/47]
Inventor(s)01 / GAULT, Victor Alan
14 Knockeden Close
Ballymoney Antrim BT53 6UE Northern Ireland / GB
02 / IRWIN, Nigel
26 Hopefield Grove
Portrush
Portrush Antrim BT56 8QJ Northern Ireland / GB
03 / FLATT, Peter
45 Station Road
Portstewart Co Londonderry Northern Ireland BT55 7HH / GB
 [2017/49]
Former [2014/47]01 / GAULT, Victor Alan
14 Knockeden Close
Ballymoney Antrim BT53 6UE Northern Ireland / GB
02 / IRWIN, Nigel
26 Hopefield Grove
Portrush
Portrush Antrim BT56 8QJ Northern Ireland / GB
03 / FLATT, Peter
8 Willan Drive
Portrush Antrim BT56 8PU Northern Ireland / GB
Representative(s)Dehns
St. Bride's House
10 Salisbury Square
London EC4Y 8JD / GB
[N/P]
Former [2014/47]Gardner, Rebecca Katherine
Dehns
St Bride's House
10 Salisbury Square
London EC4Y 8JD / GB
Application number, filing date13700347.114.01.2013
[2017/49]
WO2013GB50069
Priority number, dateGB2012000050912.01.2012         Original published format: GB 201200509
GB2012000789504.05.2012         Original published format: GB 201207895
[2014/47]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013104929
Date:18.07.2013
Language:EN
[2013/29]
Type: A1 Application with search report 
No.:EP2802598
Date:19.11.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 18.07.2013 takes the place of the publication of the European patent application.
[2014/47]
Type: B1 Patent specification 
No.:EP2802598
Date:06.12.2017
Language:EN
[2017/49]
Search report(s)International search report - published on:EP18.07.2013
ClassificationIPC:C07K14/47, A61K38/17, A61P3/10, A61P3/04
[2014/47]
CPC:
A61K38/1709 (EP,US); A61K38/22 (US); A61K45/06 (US);
A61P3/04 (EP); A61P3/10 (EP); C07K14/47 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/47]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:PEPTIDE UND PEPTIDDERIVATE AUF XENINBASIS[2014/47]
English:PEPTIDES AND PEPTIDE DERIVATIVES BASED ON XENIN[2014/47]
French:PEPTIDES ET DÉRIVÉS PEPTIDIQUES À LA BASE DE XÉNINE[2014/47]
Entry into regional phase11.08.2014National basic fee paid 
11.08.2014Designation fee(s) paid 
11.08.2014Examination fee paid 
Examination procedure11.08.2014Examination requested  [2014/47]
11.03.2015Amendment by applicant (claims and/or description)
24.02.2016Despatch of a communication from the examining division (Time limit: M04)
02.06.2016Reply to a communication from the examining division
28.06.2017Communication of intention to grant the patent
24.10.2017Fee for grant paid
24.10.2017Fee for publishing/printing paid
24.10.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  24.02.2016
Opposition(s)07.09.2018No opposition filed within time limit [2018/46]
Fees paidRenewal fee
30.01.2015Renewal fee patent year 03
26.01.2016Renewal fee patent year 04
17.01.2017Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.01.2013
AL06.12.2017
AT06.12.2017
CY06.12.2017
CZ06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
HR06.12.2017
LT06.12.2017
LV06.12.2017
MC06.12.2017
MK06.12.2017
NL06.12.2017
PL06.12.2017
PT06.12.2017
RO06.12.2017
RS06.12.2017
SE06.12.2017
SI06.12.2017
SK06.12.2017
SM06.12.2017
TR06.12.2017
LU14.01.2018
MT14.01.2018
BE31.01.2018
CH31.01.2018
LI31.01.2018
BG06.03.2018
NO06.03.2018
GR07.03.2018
IS06.04.2018
[2020/33]
Former [2020/31]HU14.01.2013
AT06.12.2017
CY06.12.2017
CZ06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
HR06.12.2017
LT06.12.2017
LV06.12.2017
MC06.12.2017
MK06.12.2017
NL06.12.2017
PL06.12.2017
PT06.12.2017
RO06.12.2017
RS06.12.2017
SE06.12.2017
SI06.12.2017
SK06.12.2017
SM06.12.2017
TR06.12.2017
LU14.01.2018
MT14.01.2018
BE31.01.2018
CH31.01.2018
LI31.01.2018
BG06.03.2018
NO06.03.2018
GR07.03.2018
Former [2020/28]HU14.01.2013
AT06.12.2017
CZ06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
HR06.12.2017
LT06.12.2017
LV06.12.2017
MC06.12.2017
NL06.12.2017
PL06.12.2017
PT06.12.2017
RO06.12.2017
RS06.12.2017
SE06.12.2017
SI06.12.2017
SK06.12.2017
SM06.12.2017
TR06.12.2017
LU14.01.2018
MT14.01.2018
BE31.01.2018
CH31.01.2018
LI31.01.2018
BG06.03.2018
NO06.03.2018
GR07.03.2018
Former [2020/16]AT06.12.2017
CZ06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
HR06.12.2017
LT06.12.2017
LV06.12.2017
MC06.12.2017
NL06.12.2017
PL06.12.2017
RO06.12.2017
RS06.12.2017
SE06.12.2017
SI06.12.2017
SK06.12.2017
SM06.12.2017
TR06.12.2017
LU14.01.2018
MT14.01.2018
BE31.01.2018
CH31.01.2018
LI31.01.2018
BG06.03.2018
NO06.03.2018
GR07.03.2018
Former [2020/08]AT06.12.2017
CZ06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
HR06.12.2017
LT06.12.2017
LV06.12.2017
MC06.12.2017
NL06.12.2017
PL06.12.2017
RO06.12.2017
RS06.12.2017
SE06.12.2017
SI06.12.2017
SK06.12.2017
SM06.12.2017
LU14.01.2018
MT14.01.2018
BE31.01.2018
CH31.01.2018
LI31.01.2018
BG06.03.2018
NO06.03.2018
GR07.03.2018
Former [2018/52]AT06.12.2017
CZ06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
HR06.12.2017
LT06.12.2017
LV06.12.2017
MC06.12.2017
NL06.12.2017
PL06.12.2017
RO06.12.2017
RS06.12.2017
SE06.12.2017
SI06.12.2017
SK06.12.2017
SM06.12.2017
LU14.01.2018
BE31.01.2018
CH31.01.2018
LI31.01.2018
BG06.03.2018
NO06.03.2018
GR07.03.2018
Former [2018/50]AT06.12.2017
CZ06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
HR06.12.2017
LT06.12.2017
LV06.12.2017
MC06.12.2017
NL06.12.2017
PL06.12.2017
RO06.12.2017
RS06.12.2017
SE06.12.2017
SK06.12.2017
SM06.12.2017
LU14.01.2018
BE31.01.2018
BG06.03.2018
NO06.03.2018
GR07.03.2018
Former [2018/47]AT06.12.2017
CZ06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
HR06.12.2017
LT06.12.2017
LV06.12.2017
MC06.12.2017
NL06.12.2017
PL06.12.2017
RO06.12.2017
RS06.12.2017
SE06.12.2017
SK06.12.2017
SM06.12.2017
LU14.01.2018
BG06.03.2018
NO06.03.2018
GR07.03.2018
Former [2018/44]AT06.12.2017
CZ06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
HR06.12.2017
LT06.12.2017
LV06.12.2017
MC06.12.2017
NL06.12.2017
PL06.12.2017
RO06.12.2017
RS06.12.2017
SE06.12.2017
SK06.12.2017
SM06.12.2017
BG06.03.2018
NO06.03.2018
GR07.03.2018
Former [2018/40]AT06.12.2017
CZ06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
HR06.12.2017
LT06.12.2017
LV06.12.2017
NL06.12.2017
PL06.12.2017
RO06.12.2017
RS06.12.2017
SE06.12.2017
SK06.12.2017
SM06.12.2017
BG06.03.2018
NO06.03.2018
GR07.03.2018
Former [2018/38]AT06.12.2017
CZ06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
HR06.12.2017
LT06.12.2017
LV06.12.2017
NL06.12.2017
PL06.12.2017
RS06.12.2017
SE06.12.2017
SK06.12.2017
SM06.12.2017
BG06.03.2018
NO06.03.2018
GR07.03.2018
Former [2018/37]CZ06.12.2017
EE06.12.2017
ES06.12.2017
FI06.12.2017
HR06.12.2017
LT06.12.2017
LV06.12.2017
NL06.12.2017
PL06.12.2017
RS06.12.2017
SE06.12.2017
SK06.12.2017
SM06.12.2017
BG06.03.2018
NO06.03.2018
GR07.03.2018
Former [2018/34]ES06.12.2017
FI06.12.2017
HR06.12.2017
LT06.12.2017
LV06.12.2017
NL06.12.2017
RS06.12.2017
SE06.12.2017
BG06.03.2018
NO06.03.2018
GR07.03.2018
Former [2018/24]ES06.12.2017
FI06.12.2017
HR06.12.2017
LT06.12.2017
LV06.12.2017
RS06.12.2017
SE06.12.2017
BG06.03.2018
NO06.03.2018
GR07.03.2018
Former [2018/22]ES06.12.2017
FI06.12.2017
LT06.12.2017
NO06.03.2018
Cited inInternational search[A]WO2009108621  (UNIV WASHINGTON [US], et al) [A] 1-23 * the whole document *;
 [T]  - CHRISTINE M.A. MARTIN ET AL, "Degradation, insulin secretion, glucose-lowering and GIP additive actions of a palmitate-derivatised analogue of xenin-25", BIOCHEMICAL PHARMACOLOGY, (20120801), vol. 84, no. 3, doi:10.1016/j.bcp.2012.04.015, ISSN 0006-2952, pages 312 - 319, XP055056479

DOI:   http://dx.doi.org/10.1016/j.bcp.2012.04.015
 [A]  - B. M. WICE ET AL, "Xenin-25 Potentiates Glucose-dependent Insulinotropic Polypeptide Action via a Novel Cholinergic Relay Mechanism", JOURNAL OF BIOLOGICAL CHEMISTRY, (20100625), vol. 285, no. 26, doi:10.1074/jbc.M110.129304, ISSN 0021-9258, pages 19842 - 19853, XP055056411 [A] 1-23 * the whole document *

DOI:   http://dx.doi.org/10.1074/jbc.M110.129304
 [A]  - NIGEL IRWIN ET AL, "GIP(Lys 16 PAL) and GIP(Lys 37 PAL): Novel Long-Acting Acylated Analogues of Glucose-Dependent Insulinotropic Polypeptide with Improved Antidiabetic Potential", JOURNAL OF MEDICINAL CHEMISTRY, (20060201), vol. 49, no. 3, doi:10.1021/jm0509997, ISSN 0022-2623, pages 1047 - 1054, XP055044385 [A] 1-23 * the whole document *

DOI:   http://dx.doi.org/10.1021/jm0509997
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.